This page was translated automatically from Turkish. Read the original

Bu sayfa, 26. Dünya Psikiyatri Kongresi'nde sunulan çalışmanın yapay zekâ desteğiyle hazırlanmış Türkçe özetidir. Çalışmanın sahibi sunan yazarlardır; atıf için orijinal kaynağa başvurun.

Improving sleep with adapted CBT-I in routine care for bipolar and related disorders

SO382a - IMPROVING SLEEP IN BIPOLAR AND RELATED DISORDERS THROUGH ADAPTED CBT‑I IN ROUTINE CARE (ID 3181)

Adapted CBT-I delivered in routine psychiatric care produces significant and sustained reductions in insomnia severity compared with psychoeducation in bipolar and related disorders.

The study aimed to evaluate the effectiveness and safety of an adapted protocol of cognitive behavioural therapy for insomnia (CBT-I) in real-world clinical practice. Eighty-seven participants from two psychiatric clinics were randomised to an eight-week adapted group-based CBT-I intervention or psychoeducation; assessments were conducted before, midway through, and after treatment, and at three-month follow-up. The primary outcome was insomnia severity, measured using the Insomnia Severity Index (ISI), and analyses were conducted on an intention-to-treat basis using linear mixed models; safety was assessed through participant-reported side effects and therapist-reported adverse events. Protocol adaptations included sleep compression, psychoeducation, daylight exposure and fixed mealtimes to support circadian rhythms, and stimulus control instructions. At the end of treatment, the group-by-time interaction was statistically significant in favour of CBT-I (poster p = 0.013; conference abstract p = 0.0126), and a large within-group reduction was observed in the CBT-I group (Cohen's d = -1.17; 95% confidence interval -1.65 to -0.69). Improvements were maintained throughout follow-up, the between-group difference increased, and the proportion of responders at three-month follow-up was 52% in the CBT-I group and 24% in the psychoeducation group. Regarding safety, the poster reported no treatment-related adverse events; the conference abstract stated that side effects were more frequent in the CBT-I arm midway through treatment but similar between groups at the end of treatment, and that none of the three adverse events was considered related to study participation. The authors conclude that adapted CBT-I delivered in routine psychiatric care reduces insomnia severity, has sustained effects, appears safe and acceptable, and should be considered part of the comprehensive treatment of bipolar disorder.

Tüm WCP 2026 özetleri